Amphinex
Amphinex is a photosensitising agent used in photodynamic therapy for treating superficial cancers.
It has had promising preliminary results in early trials on patients with advanced head and neck cancer[1] [2] [3]
References[edit | edit source]
- ↑ "Archived copy". Archived from the original on 2011-07-24. Retrieved 2010-04-06.
{{cite web}}
: Unknown parameter|deadurl=
ignored (help)CS1 maint: archived copy as title (link) Successful completion of the third dose group in the Amphinex study. March 2010 - ↑ http://www.medicalnewstoday.com/articles/176431.php PCI Biotech Reports Successful Completion Of Second Dose Group In Pivotal Amphinex(R) Trial. Jan 2010
- ↑ "Inoperable cancers killed by new laser surgery" The Times. UK. 3-April-2010 p15
Amphinex Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD